Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021

The publisher's Medical Devices sector report, “Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Deep Brain Stimulators (DBS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Deep Brain Stimulators (DBS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Deep Brain Stimulators (DBS) Overview

3 Products under Development

3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies

4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development

5 Deep Brain Stimulators (DBS) Companies and Product Overview

5.1 Actipulse Neuroscience Inc Company Overview
5.1.1 Actipulse Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adaptive Neuromodulation GmbH Company Overview
5.2.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.3 Adept Neuro SA Company Overview
5.3.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Aleva Neurotherapeutics SA Company Overview
5.4.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 Allegheny Health Network Company Overview
5.5.1 Allegheny Health Network Pipeline Products & Ongoing Clinical Trials Overview
5.6 Baylor College of Medicine Company Overview
5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.7 Bioinduction Limited Company Overview
5.7.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
5.8 Boston Scientific Corp Company Overview
5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Brainsway Ltd Company Overview
5.9.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 ClearPoint Medical Company Overview
5.10.1 ClearPoint Medical Pipeline Products & Ongoing Clinical Trials Overview
5.11 ClearPoint Neuro Inc Company Overview
5.11.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Cleveland Medical Devices Inc Company Overview
5.12.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Clinatec Company Overview
5.13.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview
5.14 Deep Brain Innovations, LLC Company Overview
5.14.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Enspire DBS Therapy Inc Company Overview
5.15.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Fisher Wallace Laboratories, LLC Company Overview
5.16.1 Fisher Wallace Laboratories, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Functional Neuromodulation Inc. Company Overview
5.17.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 Louisiana State University Company Overview
5.18.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
5.19 Massachusetts General Hospital Company Overview
5.19.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.20 Massachusetts Institute of Technology Company Overview
5.20.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.21 Medtronic Plc Company Overview
5.21.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.22 National Cheng-Kung University Hospital Company Overview
5.22.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.23 NeuroOne Inc Company Overview
5.23.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Neuroparticle Corp Company Overview
5.24.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview
5.25 NeuroPro Technologies Inc Company Overview
5.25.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Neurosigma Inc Company Overview
5.26.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Newronika s.r.l. Company Overview
5.27.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.28 Nexeon MedSystems Inc Company Overview
5.28.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Nia Therapeutics Inc Company Overview
5.29.1 Nia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.30.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.31 St. Jude Medical LLC Company Overview
5.31.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.32 Sunnybrook Health Sciences Centre Company Overview
5.32.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview
5.33 SUNY Downstate Medical Center Company Overview
5.33.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.34 University of California Los Angeles Company Overview
5.34.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.35 University of California San Francisco Company Overview
5.35.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.36 University of Central Florida Company Overview
5.36.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of Florida Company Overview
5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Houston Company Overview
5.38.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of Illinois Company Overview
5.39.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Milan Company Overview
5.40.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Oxford Company Overview
5.41.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of Rochester Company Overview
5.42.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of South Florida Company Overview
5.43.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.44 Wedge Therapeutics Company Overview
5.44.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

6 Deep Brain Stimulators (DBS)- Recent Developments

6.1 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
6.2 Nov 03, 2021: BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021
6.3 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
6.4 Oct 12, 2021: BrainsWay Announces Prominent Addition to Scientific Advisory Board
6.5 Sep 09, 2021: BrainsWay to Participate in Two Upcoming Investor Conferences
6.6 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.7 Jul 28, 2021: BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021
6.8 Jul 22, 2021: NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
6.9 Jun 30, 2021: Wise Therapeutics and Soterix Medical jointly announce positive results of study combining Gamified Digital Therapeutics with neurostimulation device
6.10 Jun 03, 2021: NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
6.11 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.12 May 19, 2021: BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
6.13 May 19, 2021: Avijit Ghosh named interim executive VP for U of I System
6.14 Mar 08, 2021: BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference
6.15 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees
6.16 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil
6.17 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.18 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.19 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.20 Nov 24, 2020: Griffith researchers develop long-term implantable electronics

7 Appendix

7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer

List of Tables

Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Glossary

List of Figures

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Actipulse Neuroscience Inc
Adaptive Neuromodulation GmbH
Adept Neuro SA
Aleva Neurotherapeutics SA
Allegheny Health Network
Baylor College of Medicine
Bioinduction Limited
Boston Scientific Corp
Brainsway Ltd
ClearPoint Medical
ClearPoint Neuro Inc
Cleveland Medical Devices Inc
Clinatec
Deep Brain Innovations, LLC
Enspire DBS Therapy Inc
Fisher Wallace Laboratories, LLC
Functional Neuromodulation Inc.
Louisiana State University
Massachusetts General Hospital
Massachusetts Institute of Technology
Medtronic Plc
National Cheng-Kung University Hospital
NeuroOne Inc
Neuroparticle Corp
NeuroPro Technologies Inc
Neurosigma Inc
Newronika s.r.l.
Nexeon MedSystems Inc
Nia Therapeutics Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Sunnybrook Health Sciences Centre
SUNY Downstate Medical Center
University of California Los Angeles
University of California San Francisco
University of Central Florida
University of Florida
University of Houston
University of Illinois
University of Milan
University of Oxford
University of Rochester
University of South Florida
Wedge Therapeutics

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3926EUR$4,000USD£3,282GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7852EUR$8,000USD£6,564GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€11779EUR$12,000USD£9,847GBP

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Deep Brain Stimulators (DBS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Brain Implants Market Size, Share & Trends Analysis Report by Product (Deep Brain Stimulator, Spinal Cord Stimulator), Application (Chronic pain, Epilepsy, Parkinson's, Depression, Essential Tremor), Region, and Segment Forecasts, 2023-2030

Deep Brain Stimulation Market: Analysis by Product, Application, End Use, Region Size, Trends and Forecast up to 2029

Deep Brain Stimulation Systems Global Market Report 2024